Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 2011-06-01 (14 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MONTLUCON (03100), Allier
PHARMACIE DU FAUBOURG SAINT PIERRE : revenue, balance sheet and financial ratios
PHARMACIE DU FAUBOURG SAINT PIERRE is a French company
founded 14 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MONTLUCON (03100),
this company of category PME
shows in 2021 a revenue of 5.0 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU FAUBOURG SAINT PIERRE (SIREN 539324723)
Indicator
2024
2023
2022
2021
2020
2019
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
5 030 802 €
4 675 819 €
N/C
1 254 963 €
N/C
N/C
4 361 446 €
Net income
192 914 €
93 774 €
260 708 €
364 832 €
327 443 €
126 559 €
-195 657 €
4 542 €
123 399 €
193 971 €
EBITDA
N/C
N/C
N/C
522 989 €
392 980 €
N/C
-165 319 €
N/C
N/C
253 339 €
Net margin
N/C
N/C
N/C
7.3%
7.0%
N/C
-15.6%
N/C
N/C
4.4%
Revenue and income statement
In 2024, PHARMACIE DU FAUBOURG SAINT PIERRE generates positive net income of 193 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 194 k€ -> 193 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
192 914 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 425%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 14%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
425.161%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
13.828%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DU FAUBOURG SAINT PIERRE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2019
2020
2021
2022
2023
2024
Debt ratio
16.033
9.229
23.949
21.028
16.54
66.715
56.199
99.909
670.864
425.161
Financial autonomy
60.817
63.789
55.598
54.005
60.343
38.75
48.248
39.012
9.312
13.828
Repayment capacity
1.377
None
None
-1.275
None
2.27
2.346
None
None
None
Cash flow / Revenue
3.645%
None%
None%
-15.415%
None%
7.671%
7.575%
None%
None%
None%
Sector positioning
Debt ratio
425.162024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average+19 pts over 3 years
In 2024, the debt ratio of PHARMACIE DU FAUBOURG SAI... (425.16) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
13.83%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch-15 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DU FAUBOURG SAI... (13.8%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 200.42. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
200.421
Liquidity indicators evolution PHARMACIE DU FAUBOURG SAINT PIERRE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2019
2020
2021
2022
2023
2024
Liquidity ratio
187.377
190.4
190.051
145.588
200.31
183.186
271.647
295.864
197.234
200.421
Interest coverage
1.993
None
None
-0.232
None
0.714
0.991
None
None
None
Sector positioning
Liquidity ratio
200.422024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good-19 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DU FAUBOURG SAI... (200.42) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DU FAUBOURG SAINT PIERRE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2019
2020
2021
2022
2023
2024
Operating WCR
874 034 €
0 €
0 €
863 302 €
0 €
761 083 €
1 089 923 €
0 €
0 €
0 €
Inventory turnover (days)
66
0
0
208
0
63
57
0
0
0
Customer payment term (days)
4
0
0
14
0
0
4
0
0
0
Supplier payment term (days)
56
0
0
208
0
62
57
0
0
0
Positioning of PHARMACIE DU FAUBOURG SAINT PIERRE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DU FAUBOURG SAINT PIERRE is estimated at
2 693 222 €
(range 1 875 517€ - 4 029 214€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1875k€2693k€4029k€
2 693 222 €Range: 1 875 517€ - 4 029 214€
NAF 5 année 2024
Valuation method used
Net Income Multiple
192 914 €
×
14.0x
=2 693 222 €
Range: 1 875 517€ - 4 029 214€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU FAUBOURG SAINT PIERRE with other companies in the same sector:
Frequently asked questions about PHARMACIE DU FAUBOURG SAINT PIERRE
What is the revenue of PHARMACIE DU FAUBOURG SAINT PIERRE ?
The revenue of PHARMACIE DU FAUBOURG SAINT PIERRE in 2021 is 5.0 M€.
Is PHARMACIE DU FAUBOURG SAINT PIERRE profitable?
Yes, PHARMACIE DU FAUBOURG SAINT PIERRE generated a net profit of 193 k€ in 2024.
Where is the headquarters of PHARMACIE DU FAUBOURG SAINT PIERRE ?
The headquarters of PHARMACIE DU FAUBOURG SAINT PIERRE is located in MONTLUCON (03100), in the department Allier.
Where to find the tax return of PHARMACIE DU FAUBOURG SAINT PIERRE ?
The tax return of PHARMACIE DU FAUBOURG SAINT PIERRE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU FAUBOURG SAINT PIERRE operate?
PHARMACIE DU FAUBOURG SAINT PIERRE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart